Français
|
日本語
Company
Overview
Our Commitment
Core Values
Executive Leadership
Services
Discovery & Preclinical
Pharmacology Services
Drug Safety Assessment
General Toxicology
Safety Pharmacology
Genetic Toxicology
Early Clinical Research
Phase I-IIa
Bioequivalence Studies
Pharmacokinetics / Pharmacodynamics
Global Clinical Development (Phase II-IV)
Development and Regulatory Services
Feasibility Research
Investigator and Patient Recruitment
Project Management and Clinical Monitoring
Medical Affairs and Safety Management
Central Lab & Centralized Cardiac Services
Data Management
Biostatistics
Medical and Scientific Writing
Quality Assurance
Connecting your trials to global regions
Bioanalysis
Small Molecule Bioanalysis
Large Molecule Bioanalysis
Validated Assays
FDA Review
Global Central Lab
Global Services
Centralized Cardiac Services
ECG Devices
ECG Locations
Quality Assurance
Development & Regulatory Services
Drug Development
Biopharmaceutical Development
Regulatory Affairs
Program Management
Quality Assurance Services
Cardiac Safety Center of Excellence
Therapeutic Experience
List A-Z
List by Location
Locations
All Locations
Executive Offices
Discovery & Preclinical
Early Clinical Research
Global Clinical Development (Phase II-IV)
Bioanalysis
Central Lab
Scientific Library
Articles
Posters
Presentations
Podcasts
Case Studies
White Papers
Events
Calendar
Registration
News
News Releases
Announcements
Media Coverage
Community Service- Thailand Diary
Contact Us
Study Participation
General Inquiries
Request Literature
Executive Offices
Public Relations
Careers at MDS
Study Participation
Medical Investigators
Careers at MDS
Investors
MDS Pharma Services News
April 1, 2008
MDS Pharma Services Names Teresa Winslow and James Miskel to Senior Team
January 28, 2008
MDS Pharma Services Expands Presence in Latin America with Sao Paulo Office
January 25, 2008
MDS Pharma Services Opens Largest Phase I Clinic on U.S. West Coast
More news from MDS Inc.
Home
/
FDA Review Update
/
Latest News
FDA Review Update
Latest News
Be sure to check back regularly for the latest news and updates regarding resolution of the FDA review.
View a video message from David Spaight
Full transcript
Slide presentation
Letters from MDS Pharma Services’ President
To generic company clients
To innovator company clients
Jan. 10, 2007 MDS News Release:
FDA Clarifies Path to Review Completion for MDS Bioanalytical Clients
Feb. 1, 2007 FDA Update:
FDA Notifies Pharmaceutical Companies to Confirm or Repeat Analytic Studies Used in the Approval of a Number of Drug Products
Letter to Sponsor of Pending Abbreviated New Drug Application(s) (ANDAs)
Letter to Sponsor of an Approved Abbreviated New Drug Application(s) (ANDAs)
Letter to Sponsor of an Approved New Drug Application(s) (NDAs)
FDA Review Update
Latest News
Background
FAQs
Audits and Certifications
Contact Us
© 2007 MDS Pharma Services |
Corporate Governance
|
Legal
|
Privacy
|
Site Map
